Molecular mechanisms underlying occult hepatitis B virus infection
- PMID: 22232374
- PMCID: PMC3255968
- DOI: 10.1128/CMR.00018-11
Molecular mechanisms underlying occult hepatitis B virus infection
Abstract
Chronic hepatitis B virus (HBV) infection is a complex clinical entity frequently associated with cirrhosis and hepatocellular carcinoma (HCC). The persistence of HBV genomes in the absence of detectable surface antigenemia is termed occult HBV infection. Mutations in the surface gene rendering HBsAg undetectable by commercial assays and inhibition of HBV by suppression of viral replication and viral proteins represent two fundamentally different mechanisms that lead to occult HBV infections. The molecular mechanisms underlying occult HBV infections, including recently identified mechanisms associated with the suppression of HBV replication and inhibition of HBV proteins, are reviewed in detail. The availability of highly sensitive molecular methods has led to increased detection of occult HBV infections in various clinical settings. The clinical relevance of occult HBV infection and the utility of appropriate diagnostic methods to detect occult HBV infection are discussed. The need for specific guidelines on the diagnosis and management of occult HBV infection is being increasingly recognized; the aspects of mechanistic studies that warrant further investigation are discussed in the final section.
Figures
References
-
- Allain JP, Cox L. 2011. Challenges in hepatitis B detection among blood donors. Curr. Opin. Hematol. 18: 461–466 - PubMed
-
- Alpert E, Isselbacher KJ, Schur PH. 1971. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N. Engl. J. Med. 285: 185–189 - PubMed
-
- Alter MJ, Favero MS, Maynard JE. 1986. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J. Infect. Dis. 153: 1149–1151 - PubMed
-
- Altfeld M, et al. 1998. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J. Hepatol. 29: 306–309 - PubMed
-
- Amin J, et al. 2007. Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study. Aust. N. Z. J. Public Health 31: 475–482 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
